24.00
price up icon1.18%   0.2832
 
loading

Xencor Inc Borsa (XNCR) Ultime notizie

pulisher
09:26 AM

Principal Financial Group Inc. Sells 15,251 Shares of Xencor, Inc. (NASDAQ:XNCR) - Defense World

09:26 AM
pulisher
Nov 20, 2024

Xencor Reports Q3 2024 Earnings and Program Updates - TipRanks

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor (XNCR)'s Technical Outlook is Bright After Key Golden Cross - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Wall Street Analysts Believe Xencor (XNCR) Could Rally 53.53%: Here's is How to Trade - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 20, 2024
pulisher
Nov 20, 2024

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Nov 20, 2024
pulisher
Nov 16, 2024

(XNCR) Proactive Strategies - Stock Traders Daily

Nov 16, 2024
pulisher
Nov 15, 2024

EcoR1 Capital, LLC Increases Stake in Xencor Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

US Bancorp DE Reduces Stock Position in Xencor, Inc. (NASDAQ:XNCR) - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

Xencor CEO Dahiyat Bassil sells shares worth $80,841 - Investing.com

Nov 14, 2024
pulisher
Nov 14, 2024

Xencor executive sells shares worth $1.6 million By Investing.com - Investing.com Australia

Nov 14, 2024
pulisher
Nov 14, 2024

Xencor executive sells shares worth $1.6 million - Investing.com India

Nov 14, 2024
pulisher
Nov 13, 2024

PRIMECAP Management Bolsters Stake in Xencor Inc - GuruFocus.com

Nov 13, 2024
pulisher
Nov 13, 2024

Xencor's SWOT analysis: biotech stock faces pivotal year ahead - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Xencor's SWOT analysis: biotech stock faces pivotal year ahead By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 12, 2024

Xencor, Inc. (NASDAQ:XNCR) Analysts Just Slashed Next Year's Revenue Estimates By 14% - Yahoo Finance UK

Nov 12, 2024
pulisher
Nov 11, 2024

Xencor, Inc. (NASDAQ:XNCR) Shares Sold by Creative Planning - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor’s (XNCR) “Outperform” Rating Reiterated at BMO Capital Markets - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor (NASDAQ:XNCR) Given New $28.00 Price Target at JPMorgan Chase & Co. - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Xencor (NASDAQ:XNCR) Given Outperform Rating at Wedbush - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush’s Forecast for Xencor FY2024 Earnings? - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Increases Earnings Estimates for Xencor - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

Leerink Partnrs Brokers Lift Earnings Estimates for Xencor - MarketBeat

Nov 11, 2024
pulisher
Nov 11, 2024

What is Wedbush's Forecast for Xencor FY2024 Earnings? - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Xencor, Inc. (NASDAQ:XNCR) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Nov 10, 2024
pulisher
Nov 08, 2024

Xencor (NASDAQ:XNCR) Receives "Outperform" Rating from BMO Capital Markets - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

Xencor shares target raised, rating held on pipeline progress By Investing.com - Investing.com Canada

Nov 08, 2024
pulisher
Nov 07, 2024

Xencor shares target raised, rating held on pipeline progress - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor (NASDAQ:XNCR) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor (NASDAQ:XNCR) shareholders are up 7.9% this past week, but still in the red over the last three years - Simply Wall St

Nov 07, 2024
pulisher
Nov 07, 2024

Xencor Reports Third Quarter 2024 Financial Results - BioSpace

Nov 07, 2024
pulisher
Nov 06, 2024

Xencor Inc earnings beat by $0.27, revenue fell short of estimates - Investing.com Canada

Nov 06, 2024
pulisher
Nov 06, 2024

Xencor (XNCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Xencor: Q3 Earnings Snapshot - San Antonio Express-News

Nov 06, 2024
pulisher
Nov 05, 2024

Trading (XNCR) With Integrated Risk Controls - Stock Traders Daily

Nov 05, 2024
pulisher
Nov 04, 2024

Xencor Doses First Subject in Phase 1/2 Study of XmAb®942 in Development for Patients with Inflammatory Bowel Disease - BioSpace

Nov 04, 2024
pulisher
Nov 04, 2024

Please Don’t Call Me a ‘Genus’: The High Bar for Section 112 in the Unpredictable Arts as Illustrated by In re Xencor - IPWatchdog.com

Nov 04, 2024
pulisher
Nov 04, 2024

942 in Development for Patients with Inflammatory Bowel Disease - Business Wire

Nov 04, 2024
pulisher
Nov 01, 2024

Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect? - Yahoo Finance

Nov 01, 2024
pulisher
Oct 29, 2024

Xencor (XNCR) Expected to Beat Earnings Estimates: Should You Buy? - MSN

Oct 29, 2024
pulisher
Oct 26, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of "Buy" by Brokerages - MarketBeat

Oct 26, 2024
pulisher
Oct 26, 2024

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Buy” by Analysts - Defense World

Oct 26, 2024
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Capitalizzazione:     |  Volume (24 ore):